Matches in Nanopublications for { ?s ?p "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- NP819946.RAQw-TaYdizNfjL8LyDyDmre4nzBKPIv11YDCh8BcDiXc130_assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819946.RAQw-TaYdizNfjL8LyDyDmre4nzBKPIv11YDCh8BcDiXc130_provenance.
- NP395698.RAJR_mz25RF1vcQKVEjXeLblpL77pwzn7AaZwPGPFmLEU130_assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395698.RAJR_mz25RF1vcQKVEjXeLblpL77pwzn7AaZwPGPFmLEU130_provenance.
- NP80540.RAb6fJroMIyKkGLtBZ33nTAo8sw80yxB0HNdj52MywLbA130_assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80540.RAb6fJroMIyKkGLtBZ33nTAo8sw80yxB0HNdj52MywLbA130_provenance.
- NP939970.RAz36g0P_22gQDRufkzxlQq4vt3EspK5NYkskiJkz5KYg130_assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939970.RAz36g0P_22gQDRufkzxlQq4vt3EspK5NYkskiJkz5KYg130_provenance.
- assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90620.RAXm-I20247sOuavyhzJp1toxQQLmF5k9NTh4zXQNw-OU130_provenance.
- NP90622.RAW7P909Cu2H6bFbbPGuNROilwf5TcQ-HXXjuBSHowKBQ130_assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90622.RAW7P909Cu2H6bFbbPGuNROilwf5TcQ-HXXjuBSHowKBQ130_provenance.
- NP480783.RATJ8JRDg7BKEJ99tIlZY7UqG7Fn-71Gx7sfh8rWv3VQQ130_assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480783.RATJ8JRDg7BKEJ99tIlZY7UqG7Fn-71Gx7sfh8rWv3VQQ130_provenance.
- NP80585.RAyLEoj51KWLZCkQkAKLgfINaM0X06HSOLx_yL8fNu_dA130_assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80585.RAyLEoj51KWLZCkQkAKLgfINaM0X06HSOLx_yL8fNu_dA130_provenance.
- NP912596.RAEldRTglWjnTZXYfKcvbxWyaxR-hvXMFt9V9JkMEySP4130_assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP912596.RAEldRTglWjnTZXYfKcvbxWyaxR-hvXMFt9V9JkMEySP4130_provenance.
- NP480784.RA7eA7q8MnuAvKtuiGj5wzqDbPvokHx2kuhx1PF6kQri4130_assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480784.RA7eA7q8MnuAvKtuiGj5wzqDbPvokHx2kuhx1PF6kQri4130_provenance.
- NP912614.RA2SMLpsSuS6y70TJqtVmdxqWzyDp9NSDm5H3GtJgDxdE130_assertion description "[UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP912614.RA2SMLpsSuS6y70TJqtVmdxqWzyDp9NSDm5H3GtJgDxdE130_provenance.